SEC Form D · Amendment · filed March 8, 2019
Bridge Therapeutics, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (22)
Elizabeth G. Kelley · Birmingham, ALDirectorJames G. Sullivan · Birmingham, ALExec · DirectorDiana H. Harshbarger · Birmingham, ALDirectorDavid H. Bergstrom · Birmingham, ALDirectorJoseph S. Mullin · Birmingham, ALDirectorKelley S. Alton · Birmingham, ALExec · DirectorAlbert Swantner · Austin, TXExec · DirectorStewart Kohl · Cleveland, OHDirectorBela Schwartz · New York, NYDirectorFrank H. Roessler · New York, NYDirectorBela Szigethy · New York, NYExec · DirectorJoe H. Fairless · New York, NYDirectorTim G. Peara · Birmingham, ALExecRussell G. Kelley · Birmingham, ALPromoterSteven B. Anderson · Buffalo, NYExec · DirectorBejan Esmaili · berkeley, CADirectorAnandh Hari · Waltham, MADirectorTom Naughton · Waltham, MADirectorPaul Ciriello · Waltham, MAExec · DirectorDavid Stienes · Waltham, MADirectorTim G. Peara · Birmingham, ALExecRussell G. Kelley · Birmingham, ALPromoter Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗